CLINICAL_TRIALS
trial_result
· 2023-08-23
Clinical Trial Update: Azithromycin Treatment for the Airway Microbiome in Asthma [Phase 2]
Summary
Phase 2 clinical trial investigating azithromycin for the airway microbiome in asthma has been terminated; results posted in 2023.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: University of Chicago | Conditions: Asthma Chronic | Phase 2 | Status: TERMINATED | Results posted: 2023-08-23